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DOI 10.1016/j.stem.2009.04.013During postnatal life, hematopoietic stem
cells (HSCs) are maintained in specialized
bone marrow (BM) niches (Morrison and
Spradling, 2008; Wilson and Trumpp,
2006; Yin and Li, 2006). Cadherins are
major cell adhesion molecules respon-
sible for Ca2+-dependent cell-cell interac-
tion (Gumbiner, 1996), but the role of
cadherin function, and more specifically
N-cadherin, in HSC-niche interactions
has been controversial (Li and Zon, 2010).
In this study, we analyzed the expression
of various cadherin (cad) genes in long-
term HSCs (LT-HSCs) and subpopula-
tions of the cells isolated from the endos-
teum. We found that LT-HSCs expressed
a low level of N-cad, whereas endosteal
cell populations including mesenchymal
progenitor cells (MPCs), immature OBs,
and mature OBs expressed a variety of
cadherins at different levels. We explored
the influence of cadherin function on
HSCs by expressing a dominant-negative
mutant N-cad (DN-N-cad) and found
that it reduced the lodgment of HSCs
(anchoring to the endosteal surface) and
significantly inhibited their long-term
engraftment. Meanwhile, overexpression
of N-cadherin in HSCs promoted quies-
cence andmaintained HSC activity during
serial BM transplantation. Thesedata sug-
gest that enhanced cell adhesion may
protect HSCs against various stresses
and promote long-term maintenance of
the HSC pool. Thus, manipulation of the
signaling between stem cells and their
niche through adhesive interactions could
potentially form a basis of novel niche-
related therapies for regenerative or
cancer medicine.
First, we analyzed the expression of
several classical cadherin genes (E-, N-,
P-, R-, VE-, K-, OB-, BR-, M-cad, and194 Cell Stem Cell 6, March 5, 2010 ª2010 ECdh7) in HSCs and their niche using
a nanofluidic real-time PCR chip, the
BioMarkSystemdynamicarray (Fluidigm).
Although there is controversy over N-cad
protein expression in HSCs (Arai et al.,
2004; Foudi et al., 2009; Haug et al.,
2008; Kiel et al., 2008; Kiel et al., 2007;
Li and Zon, 2010; Xie et al., 2009; Zhang
et al., 2003), our single-cell dynamic array
assays showed that both LSK-CD34+
short-term (ST)-HSCs and CD34 LT-
HSCs expressed N-cad (Figure 1A), and
individual cells in LSK-CD34 cells highly
expressed N-cad compared to cells in
LSK-CD34+ cells (Figure 1B). In this study,
we could not detect positive signals for
E-, P-, R-, VE-, K-, OB-, BR-, M-cad,
and Cdh7 in LSK-CD34+ or CD34 cells.
Next, we examined the expression of cad-
herin family genes in fractionated cells
isolated from the endosteal region of adult
mouse BM. CD45CD31Ter119 cells
enriched from the endosteal area were
subdivided into three fractions: ALCAM+
Sca-1, ALCAMSca-1+, and ALCAM
Sca-1 cells (Figure S1 available online).
Dynamic arrays with 5 3 103 cells from
each fraction revealed that eachendosteal
fraction expressed a variety of cadherin
genes (Figure 1D; Figure S2). In particular,
N-, OB-, BR-, and M-cad were highly
expressed in the ALCAM+Sca-1 fraction.
We also found that N-cad expression in
both LSK cells and ALCAM+Sca-1 cells
increased during development (Figures
1C and 1E). The increase ofN-cad expres-
sion in HSCs and OBs correlated with an
increase in quiescent HSCs (Arai et al.,
2004), suggesting the possibility that
cadherin activity may contribute to the
cell-cycle quiescence of HSCs during
postnatal development of hematopoiesis
in BM.lsevier Inc.Recently, Kiel et al. (2008) reported that
N-cad conditional knockout mice did not
show defects in HSCs. It is possible
some molecular redundancy or compen-
sation could have occurred. To explore
whether cadherin-mediated interaction
between HSCs and BM niches plays a
role in BM reconstitution, we analyzed
the LTR activity of HSCs expressing a
DN-N-cad (see Figure S3), which inhibits
both homophilic and heterophilic N-cad-
mediated adhesion (Fujimori and Takei-
chi, 1993). We found that DN-N-cad did
not affect HSC homing (Figure 1F), but
the lodgment and LTR activity of donor
cells were significantly inhibited (Figures
1G and 1H). These data suggest that the
cadherin-mediated cell-cell interactions
between HSCs and their niches are
involved in BM reconstitution, particularly
occupancy of the niche and protection of
the HSCs from stress. The physiological
role of cadherin-mediated cell-cell adhe-
sion in HSCs under steady-state condi-
tions still needs to be investigated.
Next, we analyzed the effects of N-cad
overexpression on the cell cycle of HSCs.
We transduced a retrovirus expressing
control-GFP, wild-type (WT)-N-cad, or
b-catenin-binding region (CBR)-deleted
N-cad [N-cad/CBR(–)] (see Figure S3)
into LSK cells and analyzed the prolifera-
tion of gene-transduced cells (Figures 2A
and 2B). Overexpression of WT-N-cad in
LSK cells reduced the nuclear accumula-
tion of b-catenin on day 2 of culture
(Figure 2C) and extended the number of
days required for a single cell to reach
more than 30 cells on N-cad-Fc-coated
plates (Figure 2B). Furthermore, N-cad-
Fc induced a delay in cell division of
LSK-side-population (SP), WT-N-cad-
transduced actively cycling 2 week-old
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Figure 1. Cadherin Expression in Adult BM
(A) Dynamic array analysis of the expression of cadherinmRNAs in LSK-CD34+ and CD34 cells. Representative heat map of delta-delta Ct (DDCt) values of posi-
tive signalswas shown. Red andblue color indicates high and lowexpression of gene compare to the reference, respectively. Black indicates nodetectable signal.
(B) N-cad expression in cells in LSK-CD34+ and CD34 fractions. Representative data with N-cad TaqMan Assay mixes #1 and #2 are shown.
(C) N-cad mRNA expression in LSK cells at different growth stages (2, 4, 6, and 8 weeks old). Data represent means ± SD (*p < 0.01).
(D) Dynamic array analysis of the expression of cadherinmRNAs in fractionated endosteal cell populations (53 103 cells per sample). Representative heat map
of DDCt values was shown.
(E) Developmental changes of N-cad expression in ALCAM+Sca-1 cells. Data represent means ± SD (*p < 0.01).
(F) Effects of DN-N-cad on homing of donor cells to BM (a) and the spleen (b). Data represent means ± SD (n = 4 mice).
(G) Effects of DN-N-cad on lodgment of donor cells. Percentages of GFP+ bone-adhering cells to total GFP+ cells in BM are shown. Data represent means ± SD
(n = 4 mice per group, *p < 0.01).
(H) Effects of DN-N-cad on the LTR ability of HSCs. The percentages of GFP+ donor-derived (Ly5.1+) cells in recipient mice 1–5 months after BMT are shown.
Data represent means ± SD (n = 10 mice per group).
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pression of N-cad/CBR(–) increased the
amount of nuclear-localizing b-catenin(Figure 2C) and shortened the number of
days required for a single cell to reach
more than 30 cells compare to WT-N-Cell Stem Cecad-transfected LSK cells on both control
and N-cad-Fc-coated plates (Figure 2B).
In addition, we found that the stimulationll 6, March 5, 2010 ª2010 Elsevier Inc. 195
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Figure 2. Enhanced N-cad-Mediated Adhesion Induced Slow Cell Division and Protected HSCs from Stresses of the Myelosuppression
and Serial BMT
(A) Experimental scheme of the cell-division assay.
(B) Proliferation of LSK cells overexpressing control-GFP, WT-N-cad, and N-cad/CBR(–) on N-cad- or control-Fc-coated plates. Percentages of colonies reach-
ing a size of more than 30 cells on each day of culture are shown. Data represent means ± SD.
(C) b-catenin localization in control-GFP, WT-N-cad, and N-cad/CBR(–)-overexpressing LSK cells on day 2 of culture on N-cad-Fc-coated plates. The scale bar
represents 10 mm.
(D) Effects of the overexpression of WT-N-cad on homing of donor cells to BM (a) and the spleen (b). Data represent means ± SD (n = 4 mice).
(E) Effects of the overexpression of WT-N-cad on lodgment of donor cells. Percentages of GFP+ bone-adhering cells to total GFP+ cells in BM are shown.
Data represent means ± SD (n = 4 per group, *p < 0.01).
(F) Ratio of GFP+ LSK-SP cells to total GFP+ BMMNCs after 5 months of BMT. Data represent means ± SD (n = 5 per group, **p < 0.05).
(G) The percentage of donor derived GFP+ cells in LSK-CD34 cells in recipient BM after 3 days of the fourth 5-FU injection. Data represent means ± SD
(n = 5 mice per group, *p < 0.01).
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creased the expression levels of cell-cycle
inhibitors in WT-N-cad-overexpressing
LSK cells (Figure S5). These data suggest
that enhancement of N-cad-mediated cell
adhesion can promote slower cell division
or quiescence of HSCs in vitro.
Next, we analyzed the effect of N-cad
overexpression on the homing and lodg-
ment of donor cells. Although overexpres-
sion of WT-N-cad did not affect homing
(Figure 2D), WT-N-cad significantly en-
hanced the lodgment of donor cells at
the endosteal surface of BM (Figure 2E).
In addition, WT-N-cad overexpressing
cells were enriched in LSK-SP, the quies-
cent HSC fraction, 5 months after BM
transplantation (Figure 2F). Furthermore
WT-N-cad-overexpressing HSCs showed
a significantly higher contribution to LSK-
CD34 cells (13.04% ± 1.9%, n = 5 mice)
compared with the control-GFP-overex-
pressing cells (4.04% ± 2.3%, n = 5
mice) after repeated 5-FU administration
(Figure 2G).
On the basis of these findings, we
hypothesized that enhanced N-cad func-
tion might prevent HSC exhaustion in
serial BMT. Therefore, we asked whether
enforced expression of WT-N-cad in
HSCs could provide a protective advan-
tage during repeated BMT. In recipients
transplanted with WT-N-cad-expressing
HSCs, the ratios of WT-N-cad-overex-
pressing HSCs (GFP+ cells) were in-
creased relative toWT in PB and LSK cells
after serial BMT (Figure 2H). These data
suggest HSCs overexpressingWTN-cad-
herin are better able to withstand the
stresses of serial BMT and that enhanced
cell adhesion protects HSCs against the
loss of self-renewal capacity.
Next we examined the potential func-
tion of intracellular signaling mediated
by b-catenin and p120-catenin using
N-cad mutants defective in interaction
with these mediators [CBR(–) and JM(–),
respectively, see Figure S3]. Overexpres-
sion of both mutants did not affect the
homing of donor cells after BMT, but the(H) Percentages of GFP+ donor cells in the PB (a) and L
group, *p < 0.01, **p < 0.05).
(I) Effects of CBR(–) and JM(–) mutant N-cad on homi
(J) Effects of CBR(–) and JM(–) mutant N-cad on lodgm
sent means ± SD (n = 4 mice per group, *p < 0.01, **p
(K) Effects of N-cad/CBR(–) and N-cad/JM(–) on the L
are shown. Data represent means ± SD. Data are rep
(L) Percentages of GFP+ donor cells in PB (a) and LSK
group, *p < 0.01).CBR(–) mutant reduced and the JM(–)
mutant enhanced the lodgment activity
of donor HSCs (Figures 2I and 2J). Inter-
estingly, despite the enhanced lodgment
activity of donor cells, the JM(–) mutant
drastically suppressed the LTR activity
(Figure 2K). p120-catenin is involved in
the stabilization of cadherin (Ireton et al.,
2002), suggesting that N-cad stabilization
by p120-catenin may play a role in LTR
activity. Next, we analyzed the effects of
CBR(–) mutant in the maintenance HSC
activity in serial BMT. Excessive activa-
tion of nuclear b-catenin activity reduces
cell-cycle quiescence, resulting in HSC
exhaustion (Fleming et al., 2008; Kirstetter
et al., 2006; Scheller et al., 2006). Consis-
tent with these reports, the CBR(–) mutant
promoted transient expansion of HSCs in
the short term (primary and second recip-
ient mice) and ultimately reduced the
maintenance of HSCs during repeated
transplantation in the long term (tertiary
recipient mice) (Figures 2K and 2L). These
findings suggest that the formation of an
appropriate N-cad/catenin complex is
also involved in cell-cycle quiescence
and self-renewal activity in LT-HSCs.
Manipulation of niche components or
signaling pathways has attracted attention
because of its potential as a target for
regenerative medicine or anticancer ther-
apy (Adams et al., 2007). Here, we have
shown that WT-N-cad overexpression can
induce slow cell cycling, resulting the
long-termmaintenance of HSCs (Figure 2).
These findings suggest a strong correlation
between cell adhesion and the mainte-
nance of the quiescent state and long-
term self-renewal activity of HSCs. There-
fore, the control of the levels of adhesive
interactions between HSCs and the BM
niche could potentially provide the basis
of niche-based therapies to protect HSCs.
Like normal HSCs, leukemic stem cells
(LSCs) interact with niche in the endosteal
area (Ishikawa et al., 2007). Interaction
between LSCs and in the BM niche
causes dysfunction of normal HSCs by
occupying normal HSC niches (ColmoneSK (b) fractions after first, second, and third BMT are in
ng to BM (a) and spleen (b). Data represent means ± S
ent of donor cells. The percentages of GFP+ bone-adhe
< 0.05).
TR activity of LSK cells. Percentages of GFP+ donor-d
resentative of two independent experiments.
fractions (b) after first, second, and third BMT are ind
Cell Stem Ceet al., 2008). In fact, cell-adhesion mole-
cules are considered a potential target in
the development of therapeutic strategies
to eradicate cancer stem cells (Jin et al.,
2006). Our study raises the possibility
that antagonizing cadherin/catenin ac-
tivity could potentially repress the interac-
tion of LSCs with the niche and thereby
decrease their resistance to chemo-
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